Browsing publications by Professor David Jones

Newcastle AuthorsTitleYearFull text
Dr Vinod Hegade
Dr Stuart Kendrick
Professor David Jones
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study2017
Dr Vinod Hegade
Dr Stuart Kendrick
Professor David Jones
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial2016
Dr Jessica Dyson
Professor David Jones
Early Primary Biliary Cholangitis is Characterised by Brain Abnormalities on Cerebral Magnetic Resonance Imaging2016
Professor David Jones
Editorial: fenofibrate as second-line therapy in high risk PBC - more answers or more questions?2016
Dr Vinod Hegade
Dr Amardeep Khanna
Dr Lucy Walker
Dr Lin Lee Wong
Dr Jessica Dyson
et al.
Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score2016
Dr Vinod Hegade
Dr Richard Speight
Rachel Etherington
Professor David Jones
Novel bile acid therapeutics for the treatment of chronic liver diseases2016
Professor David Jones
Obeticholic acid for the treatment of primary biliary cirrhosis2016
Professor David Jones
POISE: A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis2016
Dr Phillip Probert
Dr Jeremy Palmer
Dr Aimen Amer
Steven White
Professor David Jones
et al.
Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1′-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism2016
Dr Jessica Dyson
Dr Nina Wilkinson
Dr Laura Jopson
Samantha Ducker
Dr Deborah Stocken
et al.
The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis2016
1234567891011121314151617181920...